ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.
Location: United States, Florida, Miramar
Employees: 11-50
Total raised: $10.7M
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | Westlake V... | westlakeve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.06.2015 | - | $10.7M | - |
Mentions in press and media 5
| Date | Title | Description |
| 13.04.2017 | Altor BioScience and CMC Biologics Announce Agreement for Manufacture and Validation of Altor’s IL-15 Superagonist Molecule, ALT-803, for use in Phase 3 Clinical Trials | CMC ICOS Biologics, Inc. (“CMC Biologics”), a global leader in clinical and commercial manufacturing of therapeutic proteins, and Altor BioScience Corporation (“Altor”), a leading developer of novel cytokine-based immunotherapeutics for can... |
| 02.06.2015 | Cancer immunotherapy player Altor BioScience raises $10.7M | Altor BioScience has been working on this approach for more than two decades, yet it remains venture-funded, with some revenue from creating reagents for research. It looks like Altor’s core science may finally be coming close to an inflect... |
| 02.03.2010 | Altor Secures $10M Series B Funding | Altor Networks, a Redwood Shores, California-based provider of security for virtualized data centers and clouds, has closed a $10m Series B funding round. Participants in the round include new investors DAG Ventures, Juniper Networks with i... |
| 25.09.2009 | USA, Altor BioScience Awarded $3M SBIR Bridge Grant by NCI | Altor BioScience Corporation, a biotechnology company developing targeted immunotherapies for treating cancer, viral infections, and inflammatory diseases, has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant b... |
| - | Cancer immunotherapy player Altor BioScience raises $10.7M | Immunotherapy player Altor BioScience just raised a $10.7 million equity round, according to a regulatory filing. Altor BioScience engineers a way to direct the immune system to treat a number of blood cancers, bladder cancer and acute resp... |